New targeting system for antimycotic drugs: beta-glucosidase sensitive amphotericin B-star poly(ethylene glycol) conjugate

Bioorg Med Chem Lett. 2008 May 1;18(9):2952-6. doi: 10.1016/j.bmcl.2008.03.065. Epub 2008 Mar 27.

Abstract

A new targeting potentially intravenous conjugate Amphotericin B (AMB)-star poly(ethylene glycol) (sPEG) (M=25,160) has been synthesized and characterized. It contains a beta-d-glucopyranoside molecular switch which is sensitive to beta-glucosidases (E.C.3.2.1.21). The beta-glucosidase-catalyzed release of AMB from the polymeric carrier was proved in vitro by means of spectrophotometry and HPLC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / analogs & derivatives
  • Amphotericin B / chemical synthesis
  • Amphotericin B / pharmacology*
  • Antifungal Agents / chemical synthesis
  • Antifungal Agents / pharmacology*
  • Catalysis
  • Chromatography, High Pressure Liquid
  • Drug Design*
  • Humans
  • Models, Chemical
  • Polyethylene Glycols / chemical synthesis
  • Polyethylene Glycols / pharmacology*
  • Spectrophotometry, Ultraviolet
  • beta-Glucosidase / metabolism*

Substances

  • Antifungal Agents
  • Polyethylene Glycols
  • Amphotericin B
  • beta-Glucosidase